NCT00000448 - Naltrexone Treatment for Alcoholic Women | Biotech Hunter

Enrollment

160

Participants

Timeline

Start Date

October 31, 1995

Primary Completion Date

December 31, 2000

Study Completion Date

December 31, 2000

Conditions

AlcoholismEating Disorder

Interventions

DRUG

naltrexone

Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence.

DRUG

Placebo

A placebo is a simulated or otherwise medically ineffectual treatment for a disease or other medical condition intended to deceive the recipient.

Trial Locations (1)

Substance Abuse Treatment Unit, Yale University, New Haven

All Listed Sponsors

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Yale University

OTHER